Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 10, 2002, Pages 1133-1139

  Wu, C L ^a   Hung, C R ^a   Chang, F Y ^a   Pau, K Y F ^a   Wang, Paul S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cholecystokinin (CCK); Devazepide; Estradiol (E2); L 365,260; Lorglumide

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR; LORGLUMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; GEOMETRY; INTESTINE TRANSIT TIME; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STOMACH EMPTYING;

ANIMALS; BENZODIAZEPINONES; CHOLECYSTOKININ; DEVAZEPIDE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HORMONE ANTAGONISTS; OVARIECTOMY; PHENYLUREA COMPOUNDS; PROGLUMIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; TIME FACTORS;

EID: 0036793925     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202760373326     Document Type: Article

References (55)

1. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981;80:1497-500.
2. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, et al. Effect of pregnancy on gastrointestinal transit. Dig Dis Sci 1982;27:1015-8.
3. Van Thiel DH, Gavaler JS, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 1976;71:232-34.
4. Lawson M, Kern F, Everson T. Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology 1985;89:996-9.
5. Ryan JP. Effect of pregnancy on intestinal transit: comparison of results using radioactive and non-radioactive test meals. Life Sci 1982;31:2635-40.
6. Parry E, Shields R, Turnbull AC. Transit time in the small intestine in pregnancy. J Obstet Gynaecol Br Common 1970;77:900-1.
7. Datz FL, Christian PE, Moore J. Differences in gastric emptying rates between menstruating and postmenopausal women. J Nucl Med 1987;28:604-5.
8. Biggs JSG, Vesey EJ. Treatment of gastrointestinal disorders of pregnancy. Drugs 1980;19:70-6.
9. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU486) compared with high dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041-4.
10. Klebanoff MA, Koslowe PA, Kaslow R, Rhodes GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol 1985;66:612-6.
11. Chen TS, Doong ML, Chang FY, Lee SD, Wang PS. Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats. Am J Physiol 1995;268:G171-6.
12. Debas HT, Farooq O, Grossman MI. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975;68:1211-7.
13. Jin HO, Lee KY, Chang TM, Chey WY, Dubois A. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Dig Dis Sci 1994;39:2306-14.
14. Moran TH, McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol 1982;242:R491-7.
15. Moran TH, Robinson PH, Goldrich MS, McHugh PR. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 1986;362:175-9.
16. Innis RB, Synder SH. Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 1980;77:6917-21.
17. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992;89:3605-9.
18. Pisegna JR, De Weerth A, Huppi K, Wank SA. Molecular cloning of human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 1992;189:296-303.
19. Wank SA, Pisegna JR, De Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 1992;89:8691-5.
20. Silvente-Poirot S, Dufresne M, Vaysse N, Fourmy D. The peripheral cholecystokinin receptors. Eur J Biochem 1993;215:513-29.
21. Doong ML, Lu CC, Kau MM, Tsai SC, Chiao YC, Chen JJ, et al. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats. Br J Pharmacol 1998;124:1123-30.
22. Beglinger C. Effect of cholecystokinin on gastric motility in humans. Ann NY Acad Sci 1994;713:219-25.
23. Varga G, Scarpignato C. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists. Eur J Pharmacol 1996;306:153-9.
24. Reidelberger RD, O'Rourke MF. Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats. Am J Physiol 1989;257:R1512-8.
25. Makovec F, Bani M, Chiste R, Revel L, Rovati LC, Setnikar L. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats. Regul Pept 1986;16:281-90.
26. Lu L, Huang M, Liu Z, Ma L. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. Neuroreport 2000;11:829-32.
27. Hwang C, Pu HF, Hwang CY, Liu JY, Yao HC, Tung YF, et al. Age-related differences in the release of luteinizing hormone and gonadotropin-releasing hormone in ovariectomized rats. Neuroendocrinology 1990;52:127-32.
28. Wang PS, Porter JC. Hormonal modulation of the quantity and in situ activity of tyrosine hydrolase in neurites of the median eminence. Proc Natl Acad Sci USA 1986;83:9804-6.
29. Holzer P. Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br J Pharmacol 1985;86:305-12.
30. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Meth 1981;6:211-7.
31. Chen TS, Doong ML, Wang SW, Tsai SC, Lu CC, Shih HC, et al. Gastric emptying and gastrointestinal transit during lactation in rats. Am J Physiol 1997;272:G626-31.
32. Lu CC, Tsai SC, Wang SW, Tsai CL, Lau CP, Shih HC, et al. Effects of ovarian steroid hormones and thyroxine on calcitonin secretion in pregnant rats. Am J Physiol 1998;274:E246-52.
33. Steel RD, Torrie JH. Principles and procedures of statistics. New York: McGraw-Hill; 1960.
34. Thomas ML, Xu X, Norfleet AM, Watson CS. The presence of functional estrogen receptors in intestinal epithelial cells. Endocrinology 1993;132:426-30.
35. Bruce LA, Beshudi FM. Increased gastrointestinal motility in vitro following chronic estrogen treatment in male rats. Proc Soc Exp Biol Med 1981;166:355-9.
36. Austin C. Chronic and acure effects of oestrogens on vascular contractility. J Hypertens 2000;18:1365-78.
37. Shaw L, Taggart M, Austin C. Effects of the oestrous cycle and gender on acute vasodilatory responses of isolated pressurized rat mesenteric arteries to 17Β-oestradiol. Br J Pharmacol 2001;132:1055-62.
38. Altura BM, Altura BT. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle. Federation Proc 1982;43:80-6.
39. Chey WY, Hitanant S, Hendricks J, Lorber SH. Effect of secretin and cholecystokinin on gastric emptying and gastric output in man. Gastroenterology 1970;58:820-7.
40. Jin HO, Lee KY, Chang TM, Chey WY, Dubois A. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Dig Dis Sci 1994;39:2306-14
41. Ballinger AB, Clark ML. L-Phenylalanine releases cholecystokinin (CCK) and is associated with reduced food intake in humans: evidence for physiological role of CCK in control of eating. Metabolism 1994;43:735-8.
42. Gibbs J, Falasco JD, McHugh PR. CCK-decreased food intake in rhesus monkeys. Am J Physiol 1976;230:15-8.
43. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973;84:488-95.
44. Bitar KN, Makhlouf GM. Receptor on smooth muscle cell: characterization by contraction and specific antagonists. Am J Physiol 1982;242:G400-7.
45. Grider JR, Makhlouf GM. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology 1987;92:175-80.
46. Menozzi D, Gardner JD, Jensen RT, Maton PN. Properties of receptors for gastrin and CCK on gastric smooth muscles. Am J Physiol 1989;257:G73-9.
47. Grider JR, Makhlouf GM. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol 1990;259;G184-90.
48. Lloyd KCK, Raybould HE, Walsh JH. Cholecystokinin inhibits gastric acid secretion through type 'A' cholecystokinin receptors and somatostatin in rat. Am J Physiol 1992;263:G287-92.
49. Hill DR, Woodruff GN. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK 329 and L-365,260. Brain Res 1990;526:276-83.
50. Huang SC, Zhang L, Chiang HV, Wank SA, Maton PN, Gardner JD, et al. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists. Am J Physiol 1989;257:G169-74.
51. Lotti VJ, Chang RSL. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand:L365,260. Eur J Pharmacol 1989;162:273-80.
52. Moran TH, Kornbluh R, Moore K, Schwartz GJ. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites. Regul Pept 1994;52:165-72.
53. Murphy RB, Smith GP, Gibbs J. Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus. Peptides 1987;8:127-34.
54. Margolis RL, Moran TH, McHugh PR. In vitro response of rat gastrointestinal segments to cholecystokinin and bombesin. Peptides 1989;10:157-61.
55. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of rat and man. A polymerase chain reaction study. Scand J Gastroenterol 1996;31:383-90.